×
About 375 results

ALLMedicine™ Drug Eruptions Center

Research & Reviews  120 results

Patch Testing in Drug Eruptions: Practical Aspects and Literature Review of Eruptions a...
https://doi.org/10.1097/DER.0000000000000839
Dermatitis : Contact, Atopic, Occupational, Drug; de Groot AC

Jan 15th, 2022 - There is overwhelming evidence that many delayed cutaneous adverse drug reactions (beginning >6 hours after drug intake) are mediated by delayed-type (type IV) hypersensitivity, including maculopapular eruptions, erythroderma, symmetrical drug-rel...

Annular drug eruptions.
https://doi.org/10.1016/j.clindermatol.2021.12.008
Clinics in Dermatology; Wu WH, Chu CY

Jan 4th, 2022 - Cutaneous adverse drug reactions (cADRs) are undesirable cutaneous changes caused by medications. Drug eruptions can mimic a wide range of dermatoses that include exanthematous (morbilliform), urticarial, pustular, bullous, papulosquamous, or gran...

Methods for Identifying Culprit Drugs in Cutaneous Drug Eruptions: A Scoping Review.
https://doi.org/10.1177/12034754211027509
Journal of Cutaneous Medicine and Surgery; Bose R, Ogbalidet S et. al.

Nov 21st, 2021 - Cutaneous drug eruptions are a significant source of morbidity, mortality, and cost to the healthcare system. Identifying the culprit drug is essential; however, despite numerous methods being published, there are no consensus guidelines. Conduct ...

Interest of the Second Phase of the Oral Challenge Test in Patients With Suspected Long-standing Penicillin Allergy
https://clinicaltrials.gov/ct2/show/NCT04513938

Aug 30th, 2021 - The most common drug allergy reported is penicillin allergy, approximately 10% of the world's population. According to the latest studies, only 1-2% of them have a proven hypersensitivity to penicillins. Being wrongly labeled "allergic" leads to a...

Dermatomyositis Medication
http://emedicine.medscape.com/article/332783-medication

Jul 21st, 2021 - Medication Summary The goals of pharmacotherapy are to reduce morbidity and to prevent complications. In addition to the agents listed below, colchicine, alendronate, and warfarin, among other therapies, have been shown to be potentially beneficia...

see more →

Drugs  10 results see all →

Clinicaltrials.gov  3 results

Interest of the Second Phase of the Oral Challenge Test in Patients With Suspected Long-standing Penicillin Allergy
https://clinicaltrials.gov/ct2/show/NCT04513938

Aug 30th, 2021 - The most common drug allergy reported is penicillin allergy, approximately 10% of the world's population. According to the latest studies, only 1-2% of them have a proven hypersensitivity to penicillins. Being wrongly labeled "allergic" leads to a...

Severe Bullous Drug Eruption and Filgrastim
https://clinicaltrials.gov/ct2/show/NCT04651439

Jun 4th, 2021 - Toxic epidermal necrolysis (TEN) including Stevens Johnson (SJS) and Lyell syndromes represent the most severe drug eruptions. It is an allergic disorder caused by cytotoxic T lymphocytes, specific of drugs, responsible for the destruction of kera...

Dermoscopy in Diagnosis of Pigmentary Skin Lesions
https://clinicaltrials.gov/ct2/show/NCT03542539

May 31st, 2018 - Skin color affected by many agents as it is determined by several chromophores such as melanin, hemoglobin and carotenoids. Among these, melanin is the main one responsible for different skin colors. Melanin is produced by special skin cells calle...

see more →

News  17 results

Photoprotection Recommended for People of Color
https://www.medscape.com/viewarticle/951252

May 17th, 2021 - Dermatologists and other clinicians should advise their patients with skin of color to practice sensible sun protection, including wearing protective clothing, staying in the shade when outdoors, and applying a tinted sunscreen with an SPF of 30 o...

Photoprotection recommended for people of color
https://www.mdedge.com/dermatology/article/240096/diversity-medicine/photoprotection-recommended-people-color
Doug Brunk

May 13th, 2021 - Dermatologists and other clinicians should advise their patients with skin of color to practice sensible sun protection, including wearing protective clothing, staying in the shade when outdoors, and applying a tinted sunscreen with an SPF of 30 o.

Serous and Hemorrhagic Bullae on the Leg
https://www.mdedge.com/dermatology/article/209544/infectious-diseases/serous-and-hemorrhagic-bullae-leg
Jacqueline Lin Bucher, MD, Mehwish Ahmed, MD

Oct 7th, 2019 - The Diagnosis: Fracture Blisters The shave biopsy pathology demonstrated a subepidermal bulla with re-epithelialization that was clinically consistent with fracture blisters (also known as fracture bullae)(Figure). Fracture blisters are a complica.

When to suspect a severe skin reaction to an AED
https://www.mdedge.com/neurology/article/194622/epilepsy-seizures/when-suspect-severe-skin-reaction-aed
Jake Remaly

Feb 15th, 2019 - NEW ORLEANS – Most skin eruptions in patients taking antiepileptic drugs (AEDs) are relatively benign. With close supervision, some patients with epilepsy may continue treatment despite having a benign drug rash, according to a lecture at the annu.

EC approves mogamulizumab for MF, SS
https://www.mdedge.com/hematology-oncology/article/190782/lymphoma-plasma-cell-disorders/ec-approves-mogamulizumab-mf-ss
HT Staff

Nov 28th, 2018 - mycosis fungoides Micrograph showing The European Commission (EC) has granted marketing authorization for mogamulizumab (Poteligeo), a humanized monoclonal antibody directed against CCR4. This means mogamulizumab is approved for use in adults with.

see more →